Literature DB >> 16714659

MR findings in cardiac amyloidosis.

Rohan I vanden Driesen1, Richard E Slaughter, Wendy E Strugnell.   

Abstract

OBJECTIVE: The objective of our study was to describe a combination of features on MRI specific to cardiac amyloidosis.
CONCLUSION: Cardiac amyloidosis is a common cause of infiltrative heart disease. The combination of subtle widespread heterogeneous myocardial enhancement on delayed postcontrast inversion recovery T1-weighted images, which may initially be dismissed as a technical error, with ancillary features of restrictive cardiac disease is highly suggestive of cardiac amyloidosis.

Entities:  

Mesh:

Year:  2006        PMID: 16714659     DOI: 10.2214/AJR.04.0871

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography.

Authors:  Jing Wang; Xiangquan Kong; Haibo Xu; Guofeng Zhou; Dandan Chang; Dingxi Liu; Li Zhang; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  An unusual case of cardiac amyloidosis.

Authors:  Chiara Bucciarelli-Ducci; Dudley J Pennell
Journal:  J Gen Intern Med       Date:  2007-09       Impact factor: 5.128

3.  Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.

Authors:  Bo Da Nam; Sung Mok Kim; Hye Na Jung; Yiseul Kim; Yeon Hyeon Choe
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-30       Impact factor: 2.357

4.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

5.  CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis.

Authors:  James A White; Han W Kim; Dipan Shah; Nowell Fine; Ki-Young Kim; David C Wendell; Wael Al-Jaroudi; Michele Parker; Manesh Patel; Femida Gwadry-Sridhar; Robert M Judd; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

6.  Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes.

Authors:  Shaunagh McDermott; Ailbhe C O'Neill; Carole A Ridge; Jonathan D Dodd
Journal:  World J Cardiol       Date:  2012-04-26

7.  Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.

Authors:  Hiromi Hashimura; Hatsue Ishibashi-Ueda; Yumiko Yonemoto; Keiko Ohta-Ogo; Taka-Aki Matsuyama; Yoshihiko Ikeda; Yoshiaki Morita; Naoaki Yamada; Hiroki Yasui; Hiroaki Naito
Journal:  Heart Vessels       Date:  2015-03-21       Impact factor: 2.037

Review 8.  Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.

Authors:  Mathew S Maurer
Journal:  Am J Med       Date:  2015-06-17       Impact factor: 4.965

9.  Cardiac Amyloidosis Diagnosis with Magnetic Resonance Imaging: A Case Report.

Authors:  Meidi El Issa; Malik El Issa; Besma Sidia
Journal:  Cureus       Date:  2018-03-15

10.  The number of unrecognized myocardial infarction scars detected at DE-MRI increases during a 5-year follow-up.

Authors:  Raquel Themudo; Lars Johansson; Charlotte Ebeling-Barbier; Lars Lind; Håkan Ahlström; Tomas Bjerner
Journal:  Eur Radiol       Date:  2016-06-02       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.